Stay updated on Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    - Removed a MedlinePlus Genetics topic on Melanoma; a deletion of a specific disease-related topic with minimal broader impact.
    Difference
    0.2%
    Check dated 2025-10-13T09:29:38.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Updated page version to v3.2.0, added MedlinePlus Genetics topic: Melanoma, and included a government funding/operating status notice; removed previous revision reference v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:56:09.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    - Version revision updated from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:40.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Updated to v3.0.2, removed the Melanoma topic from MedlinePlus Genetics, and dropped the Back to Top link and the v3.0.1 reference.
    Difference
    0.3%
    Check dated 2025-09-14T19:53:22.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T16:54:12.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as significant new research references related to pembrolizumab and advanced melanoma. Several previous location and resource details have been removed.
    Difference
    7%
    Check dated 2025-08-31T12:13:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.